Total Payments
$9,694
2024 Payments
$1,184
Companies
34
Transactions
618
Medicare Patients
712
Medicare Billing
$78,901
Payment Breakdown by Category
Food & Beverage$9,563 (98.7%)
Education$130.53 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,563 | 612 | 98.7% |
| Education | $130.53 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,571 | 94 | $0 (2024) |
| Novo Nordisk Inc | $995.13 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $878.66 | 68 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $872.12 | 59 | $0 (2024) |
| Lilly USA, LLC | $802.63 | 64 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $773.21 | 49 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $601.96 | 44 | $0 (2022) |
| PFIZER INC. | $484.60 | 31 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $438.94 | 20 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $318.57 | 26 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,184 | 68 | Novo Nordisk Inc ($210.51) |
| 2023 | $1,439 | 76 | AstraZeneca Pharmaceuticals LP ($256.30) |
| 2022 | $849.64 | 48 | Bayer HealthCare Pharmaceuticals Inc. ($188.02) |
| 2021 | $1,139 | 72 | Boehringer Ingelheim Pharmaceuticals, Inc. ($182.97) |
| 2020 | $1,208 | 82 | AstraZeneca Pharmaceuticals LP ($273.69) |
| 2019 | $1,464 | 104 | AstraZeneca Pharmaceuticals LP ($286.18) |
| 2018 | $1,359 | 94 | AstraZeneca Pharmaceuticals LP ($255.17) |
| 2017 | $1,052 | 74 | Allergan Inc. ($190.06) |
All Payment Transactions
618 individual payment records from CMS Open Payments — Page 2 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.30 | General |
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Gastroenterology | ||||||
| 06/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Endocrinology | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: DIABETES | ||||||
| 05/16/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Genetic Disease | ||||||
| 05/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardio-renal | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: DIABETES | ||||||
| 04/22/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Neurology | ||||||
| 04/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Obesity | ||||||
| 04/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Obesity | ||||||
| 04/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: UROLOGY | ||||||
| 04/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Biological | ||||||
| 04/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Respiratory | ||||||
| 04/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.41 | General |
| 04/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 159 | 324 | $28,804 | $20,740 |
| 2022 | 4 | 175 | 326 | $28,407 | $19,671 |
| 2021 | 5 | 193 | 350 | $30,233 | $22,368 |
| 2020 | 6 | 185 | 349 | $23,895 | $16,121 |
Total Patients
712
Total Services
1,349
Medicare Billing
$78,901
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 253 | $23,018 | $15,383 | 66.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $5,229 | $4,833 | 92.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 31 | 31 | $556.76 | $524.83 | 94.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 249 | $22,669 | $14,837 | 65.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $3,519 | $3,365 | 95.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $1,590 | $868.36 | 54.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 35 | 35 | $628.60 | $601.04 | 95.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 260 | $23,725 | $15,957 | 67.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 48 | 48 | $5,640 | $5,640 | 100.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 18 | 18 | $323.28 | $323.28 | 100.0% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 13 | 13 | $325.00 | $265.94 | 81.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $220.00 | $182.47 | 82.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 104 | 256 | $19,895 | $13,106 | 65.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 24 | $2,480 | $1,888 | 76.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 18 | 18 | $450.00 | $352.44 | 78.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 17 | 17 | $305.32 | $301.19 | 98.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $340.00 | $281.69 | 82.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 12 | 17 | $425.00 | $191.63 | 45.1% |
About Dr. Jose Serrano, M.D
Dr. Jose Serrano, M.D is a General Practice healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386669778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Serrano, M.D has received a total of $9,694 in payments from pharmaceutical and medical device companies, with $1,184 received in 2024. These payments were reported across 618 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($9,563).
As a Medicare-enrolled provider, Serrano has provided services to 712 Medicare beneficiaries, totaling 1,349 services with total Medicare billing of $78,901. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Kissimmee, FL
- Active Since 07/13/2006
- Last Updated 09/20/2022
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1386669778
Products in Payments
- JARDIANCE (Drug) $989.00
- FARXIGA (Drug) $795.14
- TRELEGY ELLIPTA (Drug) $690.41
- XARELTO (Drug) $579.05
- Kerendia (Drug) $438.94
- Ozempic (Drug) $327.11
- BREZTRI (Drug) $294.60
- TOUJEO (Drug) $272.88
- JANUVIA (Drug) $259.85
- Vascepa (Drug) $241.48
- Tresiba (Drug) $204.84
- INVOKANA (Drug) $194.16
- Rybelsus (Drug) $167.48
- XIFAXAN (Drug) $155.06
- TRULICITY (Drug) $153.61
- BYDUREON (Drug) $152.49
- ELIQUIS (Drug) $152.29
- SOLIQUA 100/33 (Biological) $145.22
- VRAYLAR (Drug) $144.98
- CHANTIX (Drug) $137.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Kissimmee
Dr. Miguel Melendez Munoz, M.d, M.D
General Practice — Payments: $22,114
General Practice $22,114
Sasha Pagan, Md, MD
General Practice — Payments: $12,742
General Practice $12,742
Dr. Juan Fernandez- Maceiro, M.d, M.D
General Practice — Payments: $12,282
General Practice $12,282
Norma Perez - Torres, M.d, M.D
General Practice — Payments: $8,253
General Practice $8,253
Wanda Berrios, Md, MD
General Practice — Payments: $5,777
General Practice $5,777
Gretchen Rodriguez, M.d, M.D
General Practice — Payments: $5,554
General Practice $5,554